Literature DB >> 17990340

Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics.

Glenn E Copeland1, Russell S Kirby.   

Abstract

BACKGROUND: Although birth defects are a leading cause of death in infancy and early childhood, the proportion of all deaths to children with clinically diagnosed birth defects is not well documented. The study is intended to measure the proportion of all deaths to infants and children under age 10 occurring to children with birth defects and how and why this proportion differs from the proportion of deaths due to an underlying cause of congenital anomalies using standard mortality statistics.
METHODS: A linked file of Michigan livebirths and deaths was combined with data from a comprehensive multisource birth defects registry of Michigan livebirths born during the years 1992 through 2000. The data were analyzed to determine the mortality rate for infants and children with birth defects and for children with no reported birth defect. Mortality risk ratios were calculated. The underlying causes of death for children with birth defects were also categorized and compared to cause- specific mortality rates for the general population.
RESULTS: Congenital anomalies were the underlying cause of death for 17.8% of all infant deaths while infants with birth defects were 33.7% of all infant deaths in the study. Almost half of all Michigan deaths to children aged 1 to 2 were within the birth defects registry, though only 15.0% had an underlying cause of death of a congenital anomaly based upon standard mortality statistics. The mortality experience among children with birth defects was significantly higher than other children throughout the first 9 years of life, ranging from 4.6 for 5 year olds to 12.8 for children 1 to 2. Mortality risk ratios examined by cause of death for infants with birth defects were highest for other endocrine (28.1), other CNS (28.1), and heart (21.9) conditions. For children 1 through 9, the highest differential risk was seen for other perinatal conditions (39.0), other endocrine (29.7), other CNS (24.5), and heart (21.4).
CONCLUSIONS: Childhood mortality analyses that incorporate birth defects registry data provide a more comprehensive picture of the full burden of birth defects on mortality in infant and children and can provide an effective mechanism for monitoring the survival and mortality risks of children with selected birth defects on a population basis.

Entities:  

Mesh:

Year:  2007        PMID: 17990340     DOI: 10.1002/bdra.20391

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  18 in total

1.  Primary prevention of neural tube defects in Brazil: insights into anencephaly.

Authors:  Rubén Bronberg; José Dipierri; Emma Alfaro; Maria Teresa Sanseverino; Lavinia Schüler-Faccini
Journal:  J Community Genet       Date:  2015-08-18

2.  Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006.

Authors:  Suzanne M Gilboa; Jason L Salemi; Wendy N Nembhard; David E Fixler; Adolfo Correa
Journal:  Circulation       Date:  2010-11-22       Impact factor: 29.690

3.  Spatial and temporal analysis of infant mortality from congenital malformations in Brazil (1996-2010).

Authors:  Rubén Bronberg; Lavinia Schuler-Faccini; Virginia Ramallo; Emma Alfaro; José Dipierri
Journal:  J Community Genet       Date:  2013-10-01

4.  Racial/ethnic differences in survival of United States children with birth defects: a population-based study.

Authors:  Ying Wang; Gang Liu; Mark A Canfield; Cara T Mai; Suzanne M Gilboa; Robert E Meyer; Marlene Anderka; Glenn E Copeland; James E Kucik; Wendy N Nembhard; Russell S Kirby
Journal:  J Pediatr       Date:  2015-01-29       Impact factor: 4.406

5.  Infant mortality due to congenital malformation in Argentina (1998-2009): temporal and spatial analysis of neonatal and postneonatal components.

Authors:  Rubén Bronberg; Juan Gili; Estela Chaves; Jose Dipierri
Journal:  J Community Genet       Date:  2013-03-07

Review 6.  Environmental exposures and development.

Authors:  Donald R Mattison
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

7.  Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.

Authors:  Eric N Ouattara; Xavier Anglaret; Angela Y Wong; Jennifer Chu; Heather E Hsu; Christine Danel; Serge Eholié; Raoul Moh; Delphine Gabillard; Rochelle P Walensky; Kenneth A Freedberg
Journal:  AIDS       Date:  2012-03-13       Impact factor: 4.177

8.  Parental needs among children with birth defects: defining a parent-to-parent support network.

Authors:  A M Mathiesen; C J Frost; K M Dent; M L Feldkamp
Journal:  J Genet Couns       Date:  2012-07-24       Impact factor: 2.537

9.  Routing of Biomolecules and Transgenes' Vectors in Nuclei of Oocytes.

Authors:  Marek Malecki; Bianca Malecki
Journal:  J Fertili In Vitro       Date:  2012-04-30

10.  Frontiers in Suicide Gene Therapy of Cancer.

Authors:  Marek Malecki
Journal:  J Genet Syndr Gene Ther       Date:  2012-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.